Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,013,996
-
Share change
-
+1,119,268
-
Total reported value
-
$109,971,000
-
Put/Call ratio
-
282%
-
Price per share
-
$8.45
-
Number of holders
-
49
-
Value change
-
+$12,131,222
-
Number of buys
-
31
-
Number of sells
-
18
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q4 2016
As of 31 Dec 2016,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,013,996 shares.
The largest 10 holders included
Knoll Capital Management, LP, Cormorant Asset Management, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, FMR LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., IFP Advisors, Inc, Raymond James Financial Services Advisors, Inc., and EAM Investors, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.